SCHEMBL9109960

SCHEMBL9109960

CC1(C)Nc2nc(Cl)ccc2NC1=O

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PGR P06401 3/20 0.33
KMT2A Q03164 1/20 0.33
MGAT2 Q10469 1/20 0.32
PDK2 Q15119 1/20 0.31
PDK4 Q16654 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9110424 0.77 MEN1 (0.38) PGRKMT2AMGAT2
SCHEMBL21491516 0.75 JUN (0.35)
SCHEMBL14773426 0.74 RAD52 (0.39)
SCHEMBL25348731 0.73 PGR (0.42) PGRKMT2APDK2PDK4
SCHEMBL30540460 0.73 PGR (0.42) PGRKMT2APDK2PDK4
SCHEMBL15578826 0.68 MARK3 (0.43) PGRPDK2PDK4
SCHEMBL9076137 0.68 CHEK1 (0.44) PGR
SCHEMBL8316117 0.68 XIAP (0.50) PGRKMT2A
SCHEMBL31368886 0.68 PGR (0.35) PGRKMT2AMGAT2PDK2PDK4
SCHEMBL16563723 0.67 XIAP (0.47) PGRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5424311-A A viricides for treating viral diseases; HIV enzyme inhibitor HOESCHST AKTIENGESELLSCHAFT (DE) 1995-06-13 US disclosed
EP-0590428-A1 Azaquinoxalines, process for their preparation, and their use HOECHST AKTIENGESELLSCHAFT (DE) 1994-04-06 EP disclosed